Sandbox Reserved 1716: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
[[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]] | [[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]] | ||
===Vitamin K Cycle=== | ===Vitamin K Cycle=== | ||
Vitamin K Epoxide Reductase has a large role in the Vitamin K Cycle. The vitamin K Cycle, and the VKOR enzyme are common drug targets for thromboembolic diseases. This is because, as pictured, the vitamin K cycle is the process in which blood coagulant factors II, VII, IX, and X are activated. This promotes blood clotting, which can be dangerous and cause thromboembolic diseases such as stroke, deep vein thrombosis, and/or pulmonary embolism. | |||
===Location of Enzyme === | ===Location of Enzyme === | ||
== Structure == | == Structure == | ||
